|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 491/16 | |
| C07D 471/16 | |||
| C07D 487/16 | |||
| A61K 31/5025 | |||
| A61K 31/5365 | |||
| A61P 31/18 |
| (11) | Patento numeris | 3330272 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17201148.8 |
| Europos patento paraiškos padavimo data | 2014-04-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-06-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-02-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361824739 P | 2013-05-17 | US |
| (72) |
Coleman, Paul J., US
Hartingh, Timothy J., US
Raheem, Izzat T., US
Schreier, John, US
Sisko, John T., US
Wai, John, US
Graham, Thomas, US
Hu, Lihong, CN
Peng, Xuanjia, CN
|
| (73) |
MERCK SHARP & DOHME CORP.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS |
| FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS |